Elite Pharmaceuticals, Inc. (ELTP) Deferred Tax Liabilities, Gross

Elite Pharmaceuticals, Inc. Deferred Tax Liabilities, Gross

Elite Pharmaceuticals, Inc. (ELTP) had Deferred Tax Liabilities, Gross of $1.51 million as of 2026-03-31, per its 10-K filed 2026-06-29.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-06-29

• 2026-03-31: Deferred Tax Liabilities, Gross $1.51M.
• 2025-03-31: Deferred Tax Liabilities, Gross $1.71M.
• 2024-03-31: Deferred Tax Liabilities, Gross $2.13M.